Contineum Therapeutics Inc

CTNMNASDAQ · US

Holders

ACQUIREDStale
Stengone Carmine N.
Contineum Therapeutics Inc · NASDAQ
+2,500 sh · $2.5K
Filed 8 Sept 2026SEC Form 4view source
REDUCEDStale
Stengone Carmine N.
Contineum Therapeutics Inc · NASDAQ
−2,500 sh · $41.1K
Filed 8 Sept 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Contineum Therapeutics Inc · NASDAQ
37,916 sh · $495.2K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Contineum Therapeutics Inc · NASDAQ
69,400 sh · $906.4K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Contineum Therapeutics Inc · NASDAQ
396,273 sh · $7.0M
Filed 30 Jun 2024SEC 13Fview source